Hans Raskov

Linkedin-in Envelope

Selvstændigt virke   

Speciallæge i almen kirurgi            

Speciallæge i kir. gastroenterologi 

Selvstændigt virke som speciallæge I kirurgi 

  • Dansk Kirurgiske Selskab
  • Dansk Selskab for Gastroenterologi og Hepatologi
  • Dansk Medicinsk Selskab
  • Fellow, American Society of Colon and Rectal Surgeons

Public Library of Science (PLoS)
Cancer Biomarkers

  • Internships (registrar)

Copenhagen University Hospital Rigshospitalet, Surg. Dept. C 

Copenhagen University Hospital Rigshospitalet, Int. Med. Dept. A    

 

  • Internships, Surgery (registrar)

Copenhagen University Hospital Rigshospitalet, Surg. Dept. C 

Copenhagen Municipal Hospital, General Surg. Dept. 1   

Herlev University Hospital, Surg. Dept. D (gastroenterology)   

Gentofte University Hospital, Surg. Dept. D (gastroenterology)  

  • Related Surgical Education (registrar)

Copenhagen University Hospital Rigshospitalet, Gynaecol/Obstetrics      

Glostrup University Hospital, Orthopedic Surg. Dept A   

Hvidovre University Hospital, Dept. of Anaesthesiology         

 

  • Specialist Education (senior registrar)

Herlev University Hospital, Surg. Dept D (gastroenterology)    

Gentofte University Hospital, Surg. Dept R (thoracic surgery)   

Herlev University Hospital, Surg. Dept. H (urology)   

 

  • Specialist Education Colorectal Surgery (senior registrar)

Roskilde County Hospital, General Surg.    

Gentofte University Hospital, Surg. Dept. D (surg. gastroenterology)       

Herlev University Hospital, Surg. Dept. D (surg. gastroenterology)   

Gentofte University Hospital, Surg. Dept. D (surg. gastroenterology)      

 

  • Chief Surgeon – Colorectal Surgery                                                                                  

Gentofte University Hospital, Surg. Dept. D   

 

  • Consultant Surgeon    

Raskov´s Clinic – Gastroenterology, general surgery, colorectal surgery,

endoscopy        

 

  • Work experience, other:

Founder and CEO, Colotech A/S. Pharmaceutical development and biotech company, Copenhagen Scienc Park Symbion, Copenhagen 

  • Raskov H, Gaggar S, Tajik A, Orhan A, Gögenur I. Metabolic switch in cancer – Survival of the fittest. Eur J Cancer. 2022 Nov 26;180:30-51.  Epub ahead of print. PMID: 36527974. DOI:10.1016/j.ejca.2022.11.025 
  • Kvich L, Raskov H, Gögenur I, Bjarnsholt T. Colorectal cancer tissue contains increased bacterial biomass with a predominance of Fusobacterium sp. Conference: EuroBioFilms 2022. DOI:10.13140/RG.2.2.35268.71040 
  • Justesen TF, Orhan A, Raskov H, Nolsoe C, Gögenur I. Electroporation and Immunotherapy-Unleashing the Abscopal Effect. Cancers (Basel). 2022 Jun 10;14(12):2876. DOI:10.3390/cancers14122876. PMID: 35740542; PMCID: PMC9221311
  • Raskov H, Orhan A, Gaggar S, Gögenur I. Neutrophils and polymorphonuclear myeloid-derived suppressor cells: an emerging battleground in cancer therapy. Oncogenesis. 2022 May 3;11(1):22. doi: 10.1038/s41389-022-00398-3. PMID: 35504900.
  • Furbo S, Urbano PCM, Raskov H, Troelsen JT, Gögenur I. Furbo S, Urbano PCM, Raskov HH, Troelsen JT, Kanstrup Fiehn AM, Gögenur I. Use of Patient-Derived Organoids as a Treatment Selection Model for Colorectal Cancer: A Narrative Review. Cancers (Basel). 2022 Feb 20;14(4):1069. doi: 10.3390/cancers14041069. PMID: 35205817; PMCID: PMC8870458.
  • Bennedsen ALB, Furbo S, Bjarnsholt T, Raskov H, Gögenur I, Kvich L. The gut microbiota can orchestrate the signaling pathways in colorectal cancer. APMIS. 2022 Jan 10. doi: 10.1111/apm.13206. Epub ahead of print. PMID: 35007370.
  • Raskov H, Orhan A, Salanti A, Gaggar S, Gögenur I. Natural Killer Cells in Cancer and Cancer Immunotherapy. Cancer Lett. 2021 Nov 1;520:233-242. doi: 10.1016/j.canlet.2021.07.032. Epub 2021 Jul 22. PMID: 34302920.
  • Raskov H, Orhan A, Gaggar S, Gögenur I. Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy. Front Oncol. 2021 May 20;11:668731. doi: 10.3389/fonc.2021.668731. PMID: 34094963; PMCID: PMC8172975.
  • Vogelsang RP, Bojesen RD, Hoelmich ER, Orhan A, Buzquurz F, Cai L, Grube C, Zahid JA, Allakhverdiiev E, Raskov HH, Drakos I, Derian N, Ryan PB, Rijnbeek PR, Gögenur I. Prediction of 90-day mortality after surgery for colorectal cancer using standardized nationwide quality-assurance data. BJS Open. 2021 May 7;5(3):zrab023. doi: 10.1093/bjsopen/zrab023. PMID: 33963368; PMCID: PMC8105588.
  • Søby JH, Watt SK, Vogelsang RP, Servant F, Lelouvier B, Raskov H, Knop FK, Gögenur I. Alterations in blood microbiota after colonic cancer surgery. BJS Open. 2020 Oct 6. doi: 10.1002/bjs5.50357. Epub ahead of print. PMID: 33022149.
  • Raskov H, Orhan A, Christensen JP, Gögenur I. Cytotoxic CD8+ T cells in cancer and cancer immunotherapy. Br J Cancer. 2020 Sep 15. doi: 10.1038/s41416-020-01048-4. PMID: 32929195.
  • Orhan A, Vogelsang RP, Andersen MB, Madsen MT, Rosenkrantz EH, Raskov H, Gögenur I. The prognostic value of tumor infiltrating lymphocytes (TILs) in pancreatic cancer: a systematic review and meta-analysis. Eur J Cancer. 2020 Jun;132:71-84. doi: 10.1016/j.ejca.2020.03.013. Epub 2020 Apr 22.
  • Raskov H, Orhan A, Salanti A, Gögenur I. Premetastatic niches, exosomes and circulating tumor cells: Early mechanisms of tumor dissemination and the relation to surgery. Int J Cancer. 2020 Jun 15;146(12):3244-3255. doi: 10.1002/ijc.32820. PubMed PMID: 31808150.
  • Palmgren Colov E, Helene Degett T, Raskov H, Gögenur I. The impact of the gut microbiota on prognosis after surgery for colorectal cancer – a systematic review and meta-analysis. APMIS. 2020;128(2):162-176. doi: 10.1111/apm.13032. PubMed PMID: 32017196.
  • Raskov H, Søby JH, Troelsen J, Bojesen RD, Gögenur I. Driver Gene Mutations and Epigenetics in Colorectal Cancer. Ann Surg. 2019 Jun 7. doi:10.1097/SLA.0000000000003393. [Epub ahead of print] PubMed PMID: 31188207. 
  • Raskov H, Bjarnsholt T, Alamili M, Kragh KN, Gögenur I. [Interaction between microbiota and immune system in colorectal cancer]. Ugeskr Laeger. 2018 Nov 5;180(45). pii: V04180253. Danish. PubMed PMID: 30404713.
  • Søby J, Watt SK, Vogelsang RP, Broha A, Servant F, Raskov H, Gögenur I. Alterations in blood microbiome following laparoscopic surgery for colorectal cancer. Poster. 4th Annual European Microbiome Congress. London 13-15 Nov, 2018.
  • Raskov H, Kragh KN, Bjarnsholt T, Alamili M, Gögenur I. Bacterial biofilm formation inside colonic crypts may accelerate colorectal carcinogenesis. Clin Transl Med. 2018 Sep 17;7(1):30. doi: 10.1186/s40169-018-0209-2. PubMed PMID:30221325.
  • Raskov H, Burcharth J, Pommergaard HC. Linking Gut Microbiota to Colorectal Cancer. J Cancer. 2017 Sep 20;8(17):3378-3395. doi: 10.7150/jca.20497. eCollection 2017. Review. PubMed PMID: 29151921; PubMed Central PMCID: PMC5687151.
  •  Pommergaard HC, Burcharth J, Rosenberg J, Raskov H. The association between location, age and advanced colorectal adenoma characteristics: a propensity-matched analysis. Scand J Gastroenterol. 2017 Jan;52(1):1-4. doi: 10.1080/00365521.2016.1218929. Epub 2016 Aug 16. PubMed PMID: 27686516.
  • Raskov H, Burcharth J, Pommergaard HC, Rosenberg J. Irritable bowel syndrome, the microbiota and the gut-brain axis. Gut Microbes. 2016 Jul 29:0. [Epub ahead of print] PubMed PMID: 27472486.
  • Pommergaard HC, Burcharth J, Rosenberg J, Raskov H. Advanced age is a risk factor for proximal adenoma recurrence following colonoscopy and polypectomy. Br J Surg. 2016 Jan;103(2):e100-5. doi: 10.1002/bjs.10069. Epub 2015 Dec 15. PubMed PMID: 26667088.
  • Pommergaard HC, Burcharth J, Rosenberg J, Raskov H. Aspirin, Calcitriol, and Calcium Do Not Prevent Adenoma Recurrence in a Randomized Controlled Trial. Gastroenterology. 2016 Jan;150(1):114-122.e4. doi: 10.1053/j.gastro.2015.09.010. Epub 2015 Sep 25. PubMed PMID: 26404953.
  • Raskov H, Pommergaard HC, Burcharth J, Rosenberg J. Colorectal carcinogenesis – update and perspectives. World J Gastroenterol. 2014 Dec 28;20(48):18151-64. doi: 10.3748/wjg.v20.i48.18151. Review. PubMed PMID:25561783; PubMed Central PMCID: PMC4277953.
  • Pommergaard HC, Burcharth J, Rosenberg J, Raskov H. Chemoprevention with acetylsalicylic acid, vitamin D and calcium reduces risk of carcinogen-induced lung tumors. Anticancer Res. 2013 Nov;33(11):4767-70. PubMed PMID: 24222111.
  • Pommergaard HC, Burcharth J, Rosenberg J, Raskov H. Topical combination of diclofenac, calcipotriol, and difluoromethylornithine has beneficial effects comparable to 5-fluorouracil for the treatment of non-melanoma skin cancer in mice. J Chemother. 2014 Apr;26(2):105-10. doi: 10.1179/1973947813Y.0000000117.Epub 2013 Dec 6. PubMed PMID: 24090798.
  • Pommergaard HC, Burcharth J, Rosenberg J, Raskov H. Oral chemoprevention with acetyl salicylic Acid, vitamin D and calcium reduces the risk of tobacco carcinogen-induced bladder tumors in mice. Cancer Invest. 2013 Aug;31(7):490-3.doi: 10.3109/07357907.2013.820316. PubMed PMID: 23915073.
  • Pommergaard HC, Burcharth J, Rosenberg J, Raskov H. Combination chemoprevention with diclofenac, calcipotriol and difluoromethylornithine inhibits development of non-melanoma skin cancer in mice. Anticancer Res. 2013 Aug;33(8):3033-9. PubMed PMID: 23898057.
  • Pommergaard HC, Burcharth J, Rosenberg J, Raskov H. Topical treatment with diclofenac, calcipotriol (vitamin-D3 analog) and difluoromethylornithine (DFMO) does not prevent nonmelanoma skin cancer in mice. Cancer Invest. 2013 Feb;31(2):92-6. doi: 0.3109/07357907.2012.762782. PubMed PMID: 23362949.
  • Albrethsen J, Bøgebo R, Møller CH, Olsen JA, Raskov HH, Gammeltoft S. Candidate biomarker verification: Critical examination of a serum protein pattern for human colorectal cancer. Proteomics Clin Appl. 2012 Apr;6(3-4):182-9. doi:10.1002/prca.201100095. PubMed PMID: 22532454.
  • Raskov H. [Every seventh man with anemia suffers from colonic cancer]. Ugeskr Laeger. 2009 Feb 9;171(7):539. Danish. PubMed PMID: 19213162.
  • Albrethsen J, Bøgebo R, Olsen J, Raskov H, Gammeltoft S. Preanalytical and analytical variation of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry of human serum. Clin Chem Lab Med.2006;44(10):1243-52. PubMed PMID: 17032137.
  • Albrethsen J, Møller CH, Olsen J, Raskov H, Gammeltoft S. Human neutrophil peptides 1, 2 and 3 are biochemical markers for metastatic colorectal cancer. Eur J Cancer. 2006 Nov;42(17):3057-64. Epub 2006 Oct 2. PubMed PMID: 17015013.
  • Raskov HH. [Non-steroidal anti-inflammatory agents and prevention of colorectal adenomas and carcinomas]. Ugeskr Laeger. 2006 Jan 23;168(4):359-62. Review. Danish. PubMed PMID: 16436235.
  • Albrethsen J, Bøgebo R, Gammeltoft S, Olsen J, Winther B, Raskov H. Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker study. BMC Cancer. 2005 Jan 19;5:8. PubMed PMID: 15656915; PubMed Central PMCID: PMC548152.
  • Basse L, Raskov HH, Hjort Jakobsen D, Sonne E, Billesbølle P, Hendel HW, Rosenberg J, Kehlet H. Accelerated postoperative recovery programme after colonic resection improves physical performance, pulmonary function and body composition. Br J Surg. 2002 Apr;89(4):446-53. PubMed PMID: 11952586.
  • Bülow S, Moesgaard FA, Crone PO, Gandrup P, Holm J, Kronborg O, Hemmert-Lund H, Myrhøj T, Petersen RH, Qvist N, Raskov HH, Thomsen H. [Recurrence and survival after conventional low anterior resection for rectal cancer]. Ugeskr Laeger. 2001 Jul 2;163(27):3793-7. Danish. PubMed PMID: 11466988.
  • Wiboltt K, Raskov HH. [Systemic palliative chemotherapy with 5-fluorouracil and leucovorin in disseminated colorectal cancer]. Ugeskr Laeger. 1999 Jun 21;161(25):3827-32. Review. Danish. PubMed PMID: 10412300.
  • Raskov HH. [Adjuvant systemic chemotherapy in colon cancer]. Ugeskr Laeger. 1996 Feb 26;158(9):1222-7. Review. Danish. PubMed PMID: 8644427.
  • Raskov HH. [The value of adjuvant treatment of colorectal cancer should no longer be ignored]. Ugeskr Laeger. 1995 Sep 11;157(37):5107-8. Danish. PubMed PMID: 7502381.
  • Raskov HH. [Adjuvant radiotherapy of rectal cancer]. Ugeskr Laeger. 1995;24;157(30):4228-33. Review. Danish. PubMed PMID: 7653005.
  • Raskov HH. [Combined radiotherapy and chemotherapy as adjuvant treatment of rectal cancer]. Ugeskr Laeger. 1995 Jul 24;157(30):4223-8. Review. Danish. PubMed PMID: 7653004.
  • Andersen LP, Raskov H, Elsborg L, Holck S, Justesen T, Fischer Hansen B, Møller Nielsen C, Gaarslev K. Prevalence of antibodies against heat-stable antigens from Helicobacter pylori in patients with dyspeptic symptoms and normal persons. APMIS. 1992 Sep;100(9):779-89. PubMed PMID: 1389098.
  • Raskov H, Boesgaard S. Torsion of intra-abdominal testicle. Case report. Acta Chir Scand. 1989 Sep;155(9):483-4. PubMed PMID: 2596258.
  • Raskov HH, Moesgaard F. [Development of gas gangrene following after cholecystectomy]. Ugeskr Laeger. 1988 Apr 18;150(16):983-4. Danish. PubMed PMID:3376226.
  • Raskov H, Lanng C, Gaarslev K, Hansen BF, Hauch O. [The occurrence of Campylobacter pyloridis in patients with upper gastrointestinal dyspepsia]. Ugeskr Laeger. 1988 Mar 7;150(10):591-3. Danish. PubMed PMID: 3354080.
  • Raskov H, Lanng C, Gaarslev K, Hansen BF, Hauch O. Screening for Campylobacter pyloridis in patients with upper dyspepsia and the relation to inflammation of the human gastric antrum. Scand J Gastroenterol. 1987 Jun;22(5):568-72. PubMed PMID: 3306892.
  • Gustafsen J, Lendorf A, Raskov H, Boesby S. Ketanserin versus placebo in carcinoid syndrome. A clinical controlled trial. Scand J Gastroenterol. 1986 Sep;21(7):816-8. PubMed PMID: 3535008.
  • Raskov HH, Kirkegaard P. Gas-producing perianal infection. Acta Chir Scand. 1985;151(7):653-5. PubMed PMID: 4090897.
  • Raskov HH, Lausten GS. [Colonic diverticulitis with retroperitoneal perforation]. Ugeskr Laeger. 1984 Nov 19;146(47):3659. Danish. PubMed PMID:6515998.
  • Kirkegaard P, Raskov HH. [Gas-producing infections in the abdomen]. Ugeskr Laeger. 1983 Jul 4;145(27):2087-90. Danish. PubMed PMID: 6612836.
LAST UPDATE: MAY 2022